The increasing applications of epigenetics in disease treatment and diagnosis are driving the growth of the epigenetics market. Epigenetic modifications such as methylation, histone modifications, and microRNAs play a major role in regulating gene expression during development, cellular differentiation, oncogenesis, and other biological processes. Advances in sequencing technologies and bioinformatics approaches have enabled researchers to analyze genome-wide epigenetic patterns during various biological events. This increased understanding of epigenetic mechanisms has led to the identification of epigenetic biomarkers for various diseases including cancer. Moreover, epigenetic drugs are being developed for targeting abnormal epigenetic patterns in cancer and other diseases.
The Global epigenetics market is estimated to be valued at US$ 17.05 Bn in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the epigenetics market are L€TMOreal S.A, Procter and Gamble Company (P&G), Estee Lauder Companies Inc., The Unilever Plc, Shiseido Co. Ltd., Johnson and Johnson Limited, Kose Corporation, and Kao Corporation. These key players are focusing on developing innovative epigenetic technologies and kits for various applications.
The increasing incidence of cancer and other chronic diseases has opened up opportunities for epigenetic diagnostic technologies and drugs. Global epigenetics market size biomarkers hold potential for non-invasive screening, early detection, and prognosis evaluation of cancers. Emerging areas such as epigenetic aging clocks, epigenetic toxicology, and epigenetic epidemiology are likely to gain more attention in the coming years.
The key players are expanding globally to gain access to new markets. Establishing R&D centers, acquisitions, and collaborations with global research organizations are some of the strategies adopted by companies to strengthen their global footprint. Asia Pacific region is expected to witness fastest growth owing to increasing healthcare expenditure and rising incidence of chronic diseases.
Market Drivers
The increasing prevalence of cancer and other chronic diseases is a major factor driving the growth of the epigenetics market. According to WHO, cancer is the second leading cause of death globally and accounted for 9.6 million deaths in 2018. Epigenetic modifications play a critical role in the onset and progression of various cancer types. Development of epigenetic markers for early cancer detection and epigenetic drugs targeting dysregulated epigenetic pathways are expected to boost the market growth.
Growing application of epigenetics in non-oncology areas such as metabolic disorders, infectious diseases, cardiovascular diseases is expected to present new opportunities. Advancements in epigenetic profiling and epigenomic technologies have increased the understanding of role of epigenetics in various pathological conditions driving the demand for epigenetic solutions.
Market Restrains
High costs associated with epigenetic tools, assays and procedures may hinder broader market adoption, especially in price-sensitive developing markets. Complexity of epigenetic processes and lack of qualified researchers are challenges faced by epigenetic solution providers. Stringent regulations for developing and commercializing epigenetic diagnostic kits and therapies also impede the market growth. Compared to genomics, epigenetic mechanisms are less understood posing technical hurdles for development of robust epigenetic applications.
Segment Analysis
The global epigenetics market is dominated by kits, reagents sub segment. This is because majority of research and development activities in epigenetics requires various kits and reagents such as bisulfite conversion kits, immunohistochemistry kits, polymerase chain reaction (PCR) reagents and Western blotting reagents. Chromatin remodelling and DNA modification processes involved in epigenetic studies to understand development and disease rely heavily on these kits and reagents. The next fastest growing sub segment is DNA modification enzymes which includes DNA methyltransferases and histone acetyltransferases. These enzymes play a crucial role in epigenetic modifications and understanding their function is critical for researching various disease conditions.
Global Analysis
The North America region dominated the global epigenetics market with highest market share in 2024. Presence of major biopharmaceutical companies and research organizations along with large healthcare expenditure contributes to its leading position. Additionally, supportive government initiatives of funding cancer research further supplements market growth in the region. Asia Pacific region is poised to grow at fastest CAGR during the forecast period on back of increasing research activities in countries such as China, India and Japan along with rising awareness about epigenetics role in personalized medicine. At country level, United States represented largest market. However, China is anticipated to register highest incremental growth during forecast period owing to establishing local manufacturing facilities by major players along with progressive government policies.
Get More Insights On This Topic: https://www.ukwebwire.com/epigenetics-market-size-share-analysis-2023-2030/
Comments
0 comment